Evidence map›Paper›PMID 28282382›Full record

ArticlePLoS genetics2017

Population genetic analysis of the DARC locus (Duffy) reveals adaptation from standing variation associated with malaria resistance in humans.

Kimberly F McManus, Angela M Taravella, Brenna M Henn, Carlos D Bustamante, Martin Sikora, Omar E Cornejo

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Sudan's complex genetic admixture history drives adaptation to malaria in Sudanese Copts.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Human genetic variations conferring resistance to malaria.Journal of translational medicine · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Interpreting SNP heritability in admixed populations.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. The monogenic landscape of human infectious diseases.The Journal of allergy and clinical immunology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kimberly F McManusDepartment of Biology, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-3970-8204
Angela M TaravellaDepartment of Ecology and Evolution, Stony Brook University, Stony Brook, New York, United States of America.
Brenna M HennDepartment of Ecology and Evolution, Stony Brook University, Stony Brook, New York, United States of America.ORCID 0000-0003-4998-287X
Carlos D BustamanteDepartment of Biology, Stanford University, Stanford, California, United States of America.
Martin SikoraDepartment of Genetics, Stanford University, Stanford, California, United States of America.
Omar E CornejoDepartment of Genetics, Stanford University, Stanford, California, United States of America.ORCID 0000-0003-4076-4227
Stanford University · USStony Brook University · USNatural History Museum Aarhus · DKWashington State University · US

Funding

Supplement to Enhance Wellness and Resiliency in the Graduate EnvironmentT32GM007276 · NIGMS · STANFORD UNIVERSITY · PI MORRISON, ASHBY J. · 1985 to 2023
$32.9M
NIGMS NIH HHS T32 GM007276
6 · The paper itself

Abstract

The human DARC (Duffy antigen receptor for chemokines) gene encodes a membrane-bound chemokine receptor crucial for the infection of red blood cells by Plasmodium vivax, a major causative agent of malaria. Of the three major allelic classes segregating in human populations, the FY*O allele has been shown to protect against P. vivax infection and is at near fixation in sub-Saharan Africa, while FY*B and FY*A are common in Europe and Asia, respectively. Due to the combination of strong geographic differentiation and association with malaria resistance, DARC is considered a canonical example of positive selection in humans. Despite this, details of the timing and mode of selection at DARC remain poorly understood. Here, we use sequencing data from over 1,000 individuals in twenty-one human populations, as well as ancient human genomes, to perform a fine-scale investigation of the evolutionary history of DARC. We estimate the time to most recent common ancestor (TMRCA) of the most common FY*O haplotype to be 42 kya (95% CI: 34-49 kya). We infer the FY*O null mutation swept to fixation in Africa from standing variation with very low initial frequency (0.1%) and a selection coefficient of 0.043 (95% CI:0.011-0.18), which is among the strongest estimated in the human genome. We estimate the TMRCA of the FY*A mutation in non-Africans to be 57 kya (95% CI: 48-65 kya) and infer that, prior to the sweep of FY*O, all three alleles were segregating in Africa, as highly diverged populations from Asia and ≠Khomani San hunter-gatherers share the same FY*A haplotypes. We test multiple models of admixture that may account for this observation and reject recent Asian or European admixture as the cause.

Indexed as

Genetics, PopulationAfricaAllelesAnimalsAsiaDisease ResistanceDuffy Blood-Group SystemGene FrequencyGenome, HumanGeographyGorilla gorillaHaplotypesHumansMalaria, VivaxMutationPan paniscusACKR1 protein, humanDuffy Blood-Group SystemReceptors, Cell Surface

Identifiers

PMID28282382
PMCPMC5365118
OpenAlexW2952387488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.